These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37979946)

  • 1. Perspectives on APRN prescribing of medications for opioid use disorder: Key barriers remain.
    Chapman SA; Fraimow-Wong L; Phoenix BJ; Tierney M; Spetz J
    J Subst Use Addict Treat; 2024 Feb; 157():209215. PubMed ID: 37979946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing.
    Andraka-Christou B; Gordon AJ; Spetz J; Totaram R; Golan M; Randall-Kosich O; Harrison J; Calder S; Kertesz SG; Stein BD
    J Subst Abuse Treat; 2022 Jul; 138():108715. PubMed ID: 35067400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences on advance practice nursing education to prescribe medications for opioid use disorder.
    Phoenix BJ; Tierney M; Chapman SA; Spetz J
    Nurs Outlook; 2023; 71(3):101963. PubMed ID: 37003088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical stakeholders' perceptions of patient engagement in outpatient medication treatment for opioid use disorder: A qualitative study.
    Poulsen MN; Roe SA; Asdell PB; Rahm AK; Berrettini W
    J Subst Use Addict Treat; 2024 Mar; 158():209250. PubMed ID: 38072381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
    Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
    J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the question of financial incentives for training amongst non-adopters of MOUD in rural primary care.
    Haggerty T; Turiano NA; Turner T; Dekeseredy P; Sedney CL
    Addict Sci Clin Pract; 2022 Dec; 17(1):72. PubMed ID: 36517926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics.
    Ober AJ; Dopp AR; Clingan SE; Curtis ME; Lin C; Calhoun S; Larkins S; Black M; Hanano M; Osterhage KP; Baldwin LM; Saxon AJ; Hichborn EG; Marsch LA; Mooney LJ; Hser YI
    J Subst Use Addict Treat; 2024 Jan; 156():209194. PubMed ID: 37863356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medications for opioid use disorder: An interactive educational program developed for the nurse practitioner curriculum.
    Culp-Roche A; Vaughn J; Arms T; Roberto A; Hubbell S; Link T
    J Am Assoc Nurse Pract; 2023 Oct; 35(10):638-641. PubMed ID: 37260253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
    Speight C; Caiola C; Tyndall DE; Scott ES
    J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "They make it too hard and too many hoops to jump": system and organizational barriers to drug treatment during epidemic rates of opioid overdose.
    Dickson-Gomez J; Krechel S; Ohlrich J; Montaque HDG; Weeks M; Li J; Havens J; Spector A
    Harm Reduct J; 2024 Feb; 21(1):52. PubMed ID: 38413972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From policy to practice: Pilot program increases access to medication for opioid use disorder in rural Colorado.
    Sorrell TR; Weber M; Alvarez A; Beste N; Hollins U; Amura CR; Cook PF
    J Subst Abuse Treat; 2020 Jul; 114():108027. PubMed ID: 32527514
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Bates AE; Martin-Misener R
    Can J Nurs Res; 2022 Mar; 54(1):15-26. PubMed ID: 33615847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine.
    Andrilla CHA; Jones KC; Patterson DG
    J Rural Health; 2020 Mar; 36(2):187-195. PubMed ID: 31650634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants.
    Andraka-Christou B; Page C; Schoebel V; Buche J; Haffajee RL
    Addict Sci Clin Pract; 2022 Aug; 17(1):43. PubMed ID: 35945636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine waiver uptake among nurse practitioners and physician assistants: The role of existing waivered prescriber supply.
    Auty SG; Stein MD; Walley AY; Drainoni ML
    J Subst Abuse Treat; 2020 Aug; 115():108032. PubMed ID: 32600629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliminate the buprenorphine DEA X waiver: Justification using a policy analysis approach.
    Jones KF; O'Reilly Jacob M; Spetz J; Hailer L; Tierney M
    J Nurs Scholarsh; 2023 May; 55(3):655-664. PubMed ID: 36624606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are x-waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x-waiver trainings.
    Gordon AJ; Kenny M; Dungan M; Gustavson AM; Kelley AT; Jones AL; Hawkins E; Frank JW; Danner A; Liberto J; Hagedorn H
    Am J Addict; 2022 Mar; 31(2):152-158. PubMed ID: 35118756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of Increased Access to Buprenorphine for Medical Providers in Rural Areas: A Review of the Literature and Future Directions.
    Gregory HM; Hill VM; Parker RW
    Cureus; 2021 Nov; 13(11):e19870. PubMed ID: 34976492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding access to nurse-managed medication for opioid use disorder.
    Cos TA; Starbird LE; Lee H; Chun B; Gonnella K; Bird J; Livsey K; Bastos S; O'Brien M; Clark I; Jenkins D; Tavolaro-Ryley L
    Nurs Outlook; 2021; 69(5):848-855. PubMed ID: 33992445
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.